Exploring Predictors of Quality of Life in Older Adults With End-Stage Kidney Disease Receiving In-Center Hemodialysis
NCT ID: NCT07129083
Last Updated: 2025-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
111 participants
OBSERVATIONAL
2018-01-01
2025-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CENtral Blood Pressure Targeting: a Pragmatic RAndomized Pilot TriaL in Advanced Chronic Kidney Disease
NCT05163158
Multidisciplinary Care for Patients With Chronic Kidney Disease to Increase Their Self-management.
NCT03009084
Healthy Transitions in Late Stage Kidney Disease
NCT02085837
Evaluation of a Multidisciplinary Care Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease
NCT06495385
Frailty, Cognitive Function and Health-related Quality of Life in Older Adults With Advanced Chronic Kidney Disease.
NCT05705011
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Compared to their younger counterparts, older adults on dialysis experience more complex clinical trajectories, characterized by multi-morbidity, increased frailty, and psychosocial vulnerability. Moreover, this population often faces challenges in adhering to the demanding schedules and lifestyle restrictions associated with dialysis. These factors collectively contribute to a reduction in overall quality of life (QoL), which patients often prioritize even over life expectancy.
Numerous studies have demonstrated that many older dialysis patients are willing to trade significant lengths of life expectancy, up to nine years in some cases, in exchange for better QoL. Despite this, QoL remains a vastly underutilized metric in nephrology clinical research. Only a small fraction of randomized controlled trials include QoL as an outcome measure, and even fewer consider it as a primary endpoint.
Health-Related Quality of Life (HRQoL), a narrower construct within the broader domain of QoL, is often used as a proxy for evaluating the well-being of patients. However, HRQoL tools may not fully capture what matters most to patients, especially during major life transitions such as dialysis initiation. Furthermore, differences in HRQoL instruments can produce inconsistent evaluations of patient outcomes and influence the estimation of quality-adjusted life years (QALYs), potentially skewing health policy decisions.
In light of these concerns, there is a need to examine overall QoL among older adults receiving dialysis, moving beyond standard HRQoL assessments to capture a more holistic and patient-centered understanding of life quality in this vulnerable population.
This study aims to:
* Identify the key determinants of overall QoL in older adults undergoing ICHD.
* Examine how overall QoL relates to existing HRQoL measures.
* Evaluate whether existing HRQoL instruments adequately capture domains that are meaningful to this population.
* Explore natural groupings (clusters) of patients based on QoL and associated variables to inform future patient-centered interventions.
Study Design This is a cross-sectional, observational study reported in accordance with the Strengthening The Reporting of Observational Studies in Epidemiology (STROBE) guidelines. The study involves quantitative data collection through a structured assessment set administered face-to-face during dialysis sessions.
Participants are recruited from four hospitals in the Flanders region of Belgium between January and April 2018. Hospitals are selected to ensure a representative sample across urban, rural, academic, and regional settings.
Eligibility criteria include:
Age ≥65 years Receiving ICHD Able to provide informed consent Sufficient cognitive and language capacity to complete the questionnaire in Dutch
Exclusion criteria include:
Receiving dialysis due to an acute hospital admission Diagnosed with severe psychiatric or cognitive disorders (e.g., dementia) as documented in the medical record
Data Collection and Outcome Measures A total of 95 variables are assessed across multiple domains, guided by the International Classification of Functioning, Disability and Health (ICF) framework. Assessments are conducted during one to three consecutive dialysis sessions, depending on each participant's physical and cognitive condition. Each session lasts approximately 45 minutes.
An independent researcher with no clinical ties to the patient or dialysis unit conducts all interviews to reduce bias and minimize socially desirable responses.
Primary Outcome Measure Amnestic Comparative Self-Assessment (ACSA): A self-anchoring QoL rating scale ranging from -5 (worst period of life) to +5 (best period), based on the individual's life experiences. Participants reflect on the most positive and negative periods of their life and rate their current quality of life relative to these anchors. This tool allows for a highly individualized and sensitive measure of overall QoL.
Secondary Measures (Independent Variables) Sociodemographic Variables: Age, sex, education level, marital status, living situation Dialysis-Related Variables: Duration of dialysis, comorbidity index, dialysis adequacy Comprehensive Geriatric Assessment (CGA): Functional, psychological, and social domains including Fall Risk: STRATIFY scale, Psychological Measures: Geriatric Depression Scale (GDS-4), Nutritional Status: Nutritional Risk Screening (NRS-2002) Frailty Assessment: Groningen Frailty Indicator (GFI) Functional Status: Brussels Integrated Activity Scale (BIA) - measuring basic, instrumental, and advanced ADLs
HRQoL Instruments:
EuroQol 5-Dimension 3-Level Questionnaire (EQ-5D-3L) European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) EORTC QLQ-Myeloma Module (QLQ-MY20)
Statistical Analysis
All data are analyzed using SPSS (version 29.0.2.0). Missing values are handled using listwise deletion per questionnaire. The analysis is carried out in four stages:
1. Descriptive Statistics: Means and standard deviations for normally distributed variables, medians and interquartile ranges for non-normal distributions. Normality assessed via Shapiro-Wilk test.
2. Univariate Analyses:
Mann-Whitney U test for dichotomous variables Kruskal-Wallis test for categorical variables with more than two groups Spearman's correlation for continuous and ordinal variables
3. Multivariate Regression: Variables significantly associated with ACSA scores in univariate analysis are entered into a stepwise linear regression model to identify independent predictors of QoL.
4. Cluster Analysis: Hierarchical clustering (Ward's method) is used to determine optimal grouping, followed by K-means clustering to explore patterns of QoL across patient subgroups.
Ethical Considerations This study was reviewed and approved by the Ethical Committee of Ghent University Hospital (B670201837264). All participants are fully informed of the study's purpose and procedures and provided both written and verbal informed consent. The study complies with the Declaration of Helsinki on ethical principles for medical research involving human subjects.
Significance and Expected Outcomes
This study offers an exploration of overall QoL in older adults receiving hemodialysis. By using the ACSA alongside commonly used HRQoL instruments and a wide range of biopsychosocial variables, the findings will help:
1. Clarify which factors most strongly influence QoL in this population
2. Reveal potential mismatches between standardized HRQoL measures and patients' lived experiences
3. Inform future intervention design focused on improving well-being, not just clinical outcomes
4. Provide empirical evidence to guide the choice of QoL instruments in research and policy evaluation, including cost-effectiveness studies
Ultimately, the study is expected to contribute to more patient-centered care models and improve the integration of QoL measures into nephrology research and clinical practice.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Older adults receiving in-center hemodialysis
Adults aged 65 years and older undergoing maintenance in-center hemodialysis at four hospitals in Flanders, Belgium. Participants completed structured assessments covering overall quality of life, health-related quality of life, clinical, functional, psychological, and sociodemographic variables.
Structured assessment interview
Participants completed a structured, in-person assessment conducted during one to three dialysis sessions. The assessment included validated instruments to measure overall quality of life (ACSA), health-related quality of life (EQ-5D-3L, EORTC QLQ-C30, QLQ-MY20), and various clinical, psychological, functional, and sociodemographic factors.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Structured assessment interview
Participants completed a structured, in-person assessment conducted during one to three dialysis sessions. The assessment included validated instruments to measure overall quality of life (ACSA), health-related quality of life (EQ-5D-3L, EORTC QLQ-C30, QLQ-MY20), and various clinical, psychological, functional, and sociodemographic factors.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receiving maintenance in-center hemodialysis (ICHD)
* Able to provide informed consent
* Sufficient cognitive capacity to understand and answer study questions
* Fluent in Dutch (able to complete assessments in Dutch)
Exclusion Criteria
* Documented diagnosis of severe psychiatric illness or severe cognitive impairment (e.g., dementia)
* Unable to understand or respond adequately to the questionnaire
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dominique Van d Van de Velde, Doctorate
Role: PRINCIPAL_INVESTIGATOR
University Ghent
Wim Van Biesen, Doctorate, MD
Role: STUDY_DIRECTOR
University Ghent
Patricia De Vriendt, Doctorate
Role: STUDY_CHAIR
University Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ghent University Hospital
Ghent, Oost-Vlaanderen, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BC-11716
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.